Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?
| Author | Mohamad Amin Pourhoseingholi | en |
| Author | Sara Ashtari | en |
| Author | Seyed Moayed Alavian | en |
| Orcid | Seyed Moayed Alavian [0000-0002-4443-6602] | en |
| Issued Date | 2014-11-22 | en |
| Abstract | This article does not have abstract. | en |
| DOI | https://doi.org/10.5812/hepatmon.25540 | en |
| Keyword | Hepatitis C | en |
| Keyword | Therapy | en |
| Keyword | Sofosbuvir | en |
| Keyword | Cost | en |
| Keyword | Peginterferon | en |
| Publisher | Brieflands | en |
| Title | Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients? | en |
| Type | Editorial | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 70481-pdf.pdf
- Size:
- 41.11 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF